Study on the Pathogenesis of Retinal Vascular Diseases Based on Body Fluid Metabolomics

Enrolling by invitationOBSERVATIONAL
Enrollment

3,900

Participants

Timeline

Start Date

September 7, 2023

Primary Completion Date

October 30, 2024

Study Completion Date

December 30, 2024

Conditions
Metabolomics; Retinopathy; Etiology
Interventions
OTHER

etiology

As an important part of systems biology, metabolomics mainly detects various metabolites in the sample. Different from nucleic acids, proteins and other biological macromolecules, the relative molecular weight of these metabolites is small, generally within 1000Da, such as amino acids, carboxylic acids, carbohydrates, alcohols, amines, lipids and other special substances. Through qualitative and quantitative analysis of all endogenous low molecular weight metabolites before and after pathophysiology or gene modification stimulation, metabolomics reveals the essential characteristics of life activities and metabolism of the body, and provides guidance for exploring the pathogenesis, early diagnosis, treatment and prognosis of diseases.

Trial Locations (1)

430071

Zhongnan Hospital of Wuhan University, Wuhan

All Listed Sponsors
lead

Zhongnan Hospital

OTHER